| 000 | 01881 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518074058.0 | ||
| 264 | 0 | _c20200922 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1308-5263 | ||
| 024 | 7 |
_a10.4274/tjh.galenos.2019.2019.0083 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoca, Duygu | |
| 245 | 0 | 0 |
_aTherapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia _h[electronic resource] |
| 260 |
_bTurkish journal of haematology : official journal of Turkish Society of Haematology _c02 2020 |
||
| 300 |
_a5-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 | _aMethylation |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xadverse effects |
| 650 | 0 | 4 |
_aProtein Interaction Domains and Motifs _xdrug effects |
| 700 | 1 | _aHastar, Nurcan | |
| 700 | 1 | _aEngür, Selin | |
| 700 | 1 | _aKiraz, Yağmur | |
| 700 | 1 | _aUlu, Gizem Tuğçe | |
| 700 | 1 | _aÇekdemir, Demet | |
| 700 | 1 | _aBaran, Yusuf | |
| 773 | 0 |
_tTurkish journal of haematology : official journal of Turkish Society of Haematology _gvol. 37 _gno. 1 _gp. 5-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4274/tjh.galenos.2019.2019.0083 _zAvailable from publisher's website |
| 999 |
_c30417281 _d30417281 |
||